Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells.

Luo P, Wang N, He E, Eriksson S, Zhou J, Hu G, Zhang J, Skog S.

Pathol Oncol Res. 2010 Jun;16(2):277-83. doi: 10.1007/s12253-009-9222-5. Epub 2009 Dec 3.

PMID:
19957115
2.

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C.

BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.

3.

Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.

Nisman B, Yutkin V, Nechushtan H, Gofrit ON, Peretz T, Gronowitz S, Pode D.

Urology. 2010 Aug;76(2):513.e1-6. doi: 10.1016/j.urology.2010.04.034. Epub 2010 Jun 22.

PMID:
20573390
4.

Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker.

Luo P, He E, Eriksson S, Zhou J, Hu G, Zhang J, Skog S.

Eur J Cancer Prev. 2009 Jun;18(3):220-4. doi: 10.1097/CEJ.0b013e328329d817.

PMID:
19282758
6.

Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.

Ronkainen H, Hirvikoski P, Kauppila S, Vaarala MH.

Oncol Rep. 2011 Jan;25(1):129-33.

PMID:
21109967
8.

Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.

He Q, Mao Y, Wu J, Decker C, Merza M, Wang N, Eriksson S, Castro J, Skog S.

Int J Oncol. 2004 Oct;25(4):945-53.

PMID:
15375544
9.

Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.

Oudard S, Levalois C, Andrieu JM, Bougaran J, Validire P, Thiounn N, Poupon MF, Fourme E, Chevillard S.

Anticancer Res. 2002 Jan-Feb;22(1A):121-8.

PMID:
12017273
10.

Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

Tölle A, Jung M, Lein M, Johannsen M, Miller K, Moch H, Jung K, Kristiansen G.

BMC Cancer. 2009 Jul 21;9:248. doi: 10.1186/1471-2407-9-248.

11.
12.
13.

Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).

Wechsel HW, Petri E, Bichler KH, Feil G.

Anticancer Res. 1999 Jul-Aug;19(4A):2583-90.

PMID:
10470199
14.

Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.

Mizutani Y, Nakanishi H, Li YN, Matsubara H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara K, Takaha N, Ukimura O, Kawauchi A, Nonomura N, Bonavida B, Miki T.

Int J Oncol. 2007 Apr;30(4):919-25.

PMID:
17332931
15.

Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.

Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B.

Eur Urol. 2006 Dec;50(6):1272-7. Epub 2006 Jun 13.

PMID:
16814458
17.

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.

Visapää H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A.

Urology. 2003 Apr;61(4):845-50.

PMID:
12670587
18.

Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium.

Donald CD, Laddu A, Chandham P, Lim SD, Cohen C, Amin M, Gerton GL, Marshall FF, Petros JA.

Anticancer Res. 2001 Nov-Dec;21(6A):3739-42.

PMID:
11911241
19.

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.

Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.

Acta Pharmacol Sin. 2005 Jun;26(6):753-61.

20.

Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.

Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R.

Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.

PMID:
19898225

Supplemental Content

Support Center